Descovy 200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F9AU6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,037
Award facts
- Contract value 100% obligated
- $16,037.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded November 7, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. The contract is valued at $16,037.18 with a firm fixed price structure and represents a non-competitive set-aside. Performance will be completed by November 10, 2025, with fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle that serves as the primary pharmaceutical supply mechanism for military healthcare systems globally through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, continues its established role as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other military healthcare systems. The company's substantial IDC with DLA enables flexible sourcing of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order exemplifies the company's ongoing support of military medical supply chain requirements through the established prime vendor relationship, ensuring timely pharmaceutical availability for defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9AU6?
SPE2DR26F9AU6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26F9AU6 worth?
The government has obligated $16,037 on SPE2DR26F9AU6.
Is contract SPE2DR26F9AU6 an order under another contract?
Yes. SPE2DR26F9AU6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9AU6 competed?
The extent of competition for SPE2DR26F9AU6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award